Mori Arkin
#2529

Mori Arkin

Israel 73 years old Self-Made

Overview

Source of Wealth
Pharmaceuticals
Industry
Healthcare
Residence
Herzliya Pituach
Education
Tel Aviv University (Bachelor of Arts/Science)
Marital Status
Married
Children
3

Assets

  • Argo Group International Holdings
    372,000 shares @ -
    -
    ARGO-US
  • Clal Insurance Enterprises Holdings
    0 shares @ -
    -
    CLIS-IL
  • DigitalOcean
    762,000 shares @ -
    -
    DOCN-US
  • Keros Therapeutics
    1,602,000 shares @ -
    -
    KROS-US
  • Novolog
    42,308,000 shares @ -
    -
    NVLG-IL
  • Odysight.ai Inc.
    372,000 shares @ -
    -
    ODYS-US
  • Oncorus
    1,067,000 shares @ -
    -
    ONCR-US
  • Sol-Gel Technologies
    1,415,500 shares @ -
    -
    SLGL-US
  • Sweetgreen
    372,000 shares @ -
    -
    SG-US
  • UroGen Pharma
    1,369,000 shares @ -
    -
    URGN-US

Biography

Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company.

The Arkins eventually moved into generic drug manufacturing, founding Agis Industries.

In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock.

Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 62%.

About

His two sons are involved in the family business; his daughter is serving in the Israel Defense Forses.

Arkin is an art history buff and enjoys composing music as a hobby.